Evaluation of Treatment by Glofitamab in Combination With Rituximab or Obinutuzumab Plus CHOP in Patients With RIchter Syndrome

Conditions: Richter Syndrome Interventions: Drug: Glofitamab + Obinutuzumab Sponsors: French Innovative Leukemia Organisation; Hoffmann-La Roche Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials